HEADER TRANSFERASE 13-JUL-06 2HNY TITLE CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN TITLE 2 COMPLEX WITH NEVIRAPINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: P66; COMPND 5 EC: 2.7.7.49; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: P51; COMPND 12 EC: 2.7.7.49; COMPND 13 ENGINEERED: YES; COMPND 14 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 GENE: POL; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 9 ORGANISM_TAXID: 11676; SOURCE 10 GENE: POL; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HIV-1 REVERSE TRANSCRIPTASE, AIDS, NON-NUCLEOSIDE INHIBITOR, KEYWDS 2 NEVIRAPINE, DRUG RESISTANCE MUTATIONS, DRUG DESIGN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.REN,C.E.NICHOLS,A.STAMP,P.P.CHAMBERLAIN,D.K.STAMMERS REVDAT 3 20-OCT-21 2HNY 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2HNY 1 VERSN REVDAT 1 05-SEP-06 2HNY 0 JRNL AUTH J.REN,C.E.NICHOLS,A.STAMP,P.P.CHAMBERLAIN,R.FERRIS, JRNL AUTH 2 K.L.WEAVER,S.A.SHORT,D.K.STAMMERS JRNL TITL STRUCTURAL INSIGHTS INTO MECHANISMS OF NON-NUCLEOSIDE DRUG JRNL TITL 2 RESISTANCE FOR HIV-1 REVERSE TRANSCRIPTASES MUTATED AT JRNL TITL 3 CODONS 101 OR 138. JRNL REF FEBS J. V. 273 3850 2006 JRNL REFN ISSN 1742-464X JRNL PMID 16911530 JRNL DOI 10.1111/J.1742-4658.2006.05392.X REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1809146.320 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 37055 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.284 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1856 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.59 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3411 REMARK 3 BIN R VALUE (WORKING SET) : 0.3790 REMARK 3 BIN FREE R VALUE : 0.4470 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 206 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.031 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7629 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 79 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.79000 REMARK 3 B22 (A**2) : -3.32000 REMARK 3 B33 (A**2) : 2.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.34 REMARK 3 LOW RESOLUTION CUTOFF (A) : 30.0 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.48 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.47 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 4.190 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 6.670 ; 6.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 7.860 ; 6.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 11.400; 10.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 37.06 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HNY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1000038560. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.82657 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37104 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 0.68700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.0, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 69.80000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.80000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 32.80000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 69.80000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 44700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 444 REMARK 465 ALA A 445 REMARK 465 ALA A 446 REMARK 465 ASN A 447 REMARK 465 ARG A 448 REMARK 465 GLU A 449 REMARK 465 THR A 450 REMARK 465 LYS A 451 REMARK 465 LEU A 452 REMARK 465 GLY A 453 REMARK 465 LYS A 454 REMARK 465 GLU B 89 REMARK 465 VAL B 90 REMARK 465 GLN B 91 REMARK 465 LEU B 92 REMARK 465 GLY B 93 REMARK 465 ILE B 94 REMARK 465 GLY B 213 REMARK 465 LEU B 214 REMARK 465 THR B 215 REMARK 465 THR B 216 REMARK 465 PRO B 217 REMARK 465 ASP B 218 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 MET B 357 REMARK 465 ARG B 358 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 HIS B 361 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 52 12.87 -68.34 REMARK 500 LYS A 66 86.23 -40.51 REMARK 500 ASP A 67 -100.52 -151.76 REMARK 500 SER A 68 -141.66 -105.90 REMARK 500 GLU A 89 130.74 -36.20 REMARK 500 GLN A 91 96.85 -37.28 REMARK 500 PRO A 119 156.11 -45.38 REMARK 500 MET A 184 -116.89 54.53 REMARK 500 ILE A 270 -32.85 -139.80 REMARK 500 PRO A 321 -5.57 -55.21 REMARK 500 GLN A 332 62.53 -110.80 REMARK 500 GLN A 343 -50.34 -125.18 REMARK 500 PRO A 345 107.43 -44.19 REMARK 500 PRO A 392 35.62 -84.07 REMARK 500 PRO A 412 -162.51 -52.15 REMARK 500 LYS A 465 133.36 -175.40 REMARK 500 ASP A 471 61.16 60.60 REMARK 500 LYS A 528 160.35 -49.43 REMARK 500 LYS B 20 56.33 -140.16 REMARK 500 PRO B 97 96.10 -65.61 REMARK 500 LYS B 103 150.80 -44.71 REMARK 500 PHE B 116 3.42 -54.18 REMARK 500 SER B 163 -19.09 -49.08 REMARK 500 PRO B 176 22.09 -68.83 REMARK 500 MET B 184 -117.04 59.28 REMARK 500 LEU B 193 165.97 -49.36 REMARK 500 HIS B 235 75.10 56.79 REMARK 500 TRP B 239 98.71 -51.79 REMARK 500 ASP B 250 -80.09 -77.47 REMARK 500 LEU B 283 51.50 -112.22 REMARK 500 GLN B 343 -32.72 -131.75 REMARK 500 PHE B 346 -29.69 66.78 REMARK 500 TYR B 427 -72.90 -125.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1303 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD2 REMARK 620 2 HOH A1037 O 83.5 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 1302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NVP A 999 DBREF 2HNY A 4 537 UNP P04585 POL_HV1H2 590 1123 DBREF 2HNY B 7 428 UNP P04585 POL_HV1H2 593 1014 SEQADV 2HNY LYS A 138 UNP P04585 GLU 724 ENGINEERED MUTATION SEQADV 2HNY CSD A 280 UNP P04585 CYS 866 MODIFIED RESIDUE SEQADV 2HNY LYS B 138 UNP P04585 GLU 724 ENGINEERED MUTATION SEQRES 1 A 534 PRO ILE GLU THR VAL PRO VAL LYS LEU LYS PRO GLY MET SEQRES 2 A 534 ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU THR GLU GLU SEQRES 3 A 534 LYS ILE LYS ALA LEU VAL GLU ILE CYS THR GLU MET GLU SEQRES 4 A 534 LYS GLU GLY LYS ILE SER LYS ILE GLY PRO GLU ASN PRO SEQRES 5 A 534 TYR ASN THR PRO VAL PHE ALA ILE LYS LYS LYS ASP SER SEQRES 6 A 534 THR LYS TRP ARG LYS LEU VAL ASP PHE ARG GLU LEU ASN SEQRES 7 A 534 LYS ARG THR GLN ASP PHE TRP GLU VAL GLN LEU GLY ILE SEQRES 8 A 534 PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SER VAL THR SEQRES 9 A 534 VAL LEU ASP VAL GLY ASP ALA TYR PHE SER VAL PRO LEU SEQRES 10 A 534 ASP GLU ASP PHE ARG LYS TYR THR ALA PHE THR ILE PRO SEQRES 11 A 534 SER ILE ASN ASN LYS THR PRO GLY ILE ARG TYR GLN TYR SEQRES 12 A 534 ASN VAL LEU PRO GLN GLY TRP LYS GLY SER PRO ALA ILE SEQRES 13 A 534 PHE GLN SER SER MET THR LYS ILE LEU GLU PRO PHE ARG SEQRES 14 A 534 LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN TYR MET ASP SEQRES 15 A 534 ASP LEU TYR VAL GLY SER ASP LEU GLU ILE GLY GLN HIS SEQRES 16 A 534 ARG THR LYS ILE GLU GLU LEU ARG GLN HIS LEU LEU ARG SEQRES 17 A 534 TRP GLY LEU THR THR PRO ASP LYS LYS HIS GLN LYS GLU SEQRES 18 A 534 PRO PRO PHE LEU TRP MET GLY TYR GLU LEU HIS PRO ASP SEQRES 19 A 534 LYS TRP THR VAL GLN PRO ILE VAL LEU PRO GLU LYS ASP SEQRES 20 A 534 SER TRP THR VAL ASN ASP ILE GLN LYS LEU VAL GLY LYS SEQRES 21 A 534 LEU ASN TRP ALA SER GLN ILE TYR PRO GLY ILE LYS VAL SEQRES 22 A 534 ARG GLN LEU CSD LYS LEU LEU ARG GLY THR LYS ALA LEU SEQRES 23 A 534 THR GLU VAL ILE PRO LEU THR GLU GLU ALA GLU LEU GLU SEQRES 24 A 534 LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU PRO VAL HIS SEQRES 25 A 534 GLY VAL TYR TYR ASP PRO SER LYS ASP LEU ILE ALA GLU SEQRES 26 A 534 ILE GLN LYS GLN GLY GLN GLY GLN TRP THR TYR GLN ILE SEQRES 27 A 534 TYR GLN GLU PRO PHE LYS ASN LEU LYS THR GLY LYS TYR SEQRES 28 A 534 ALA ARG MET ARG GLY ALA HIS THR ASN ASP VAL LYS GLN SEQRES 29 A 534 LEU THR GLU ALA VAL GLN LYS ILE THR THR GLU SER ILE SEQRES 30 A 534 VAL ILE TRP GLY LYS THR PRO LYS PHE LYS LEU PRO ILE SEQRES 31 A 534 GLN LYS GLU THR TRP GLU THR TRP TRP THR GLU TYR TRP SEQRES 32 A 534 GLN ALA THR TRP ILE PRO GLU TRP GLU PHE VAL ASN THR SEQRES 33 A 534 PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU GLU LYS GLU SEQRES 34 A 534 PRO ILE VAL GLY ALA GLU THR PHE TYR VAL ASP GLY ALA SEQRES 35 A 534 ALA ASN ARG GLU THR LYS LEU GLY LYS ALA GLY TYR VAL SEQRES 36 A 534 THR ASN ARG GLY ARG GLN LYS VAL VAL THR LEU THR ASP SEQRES 37 A 534 THR THR ASN GLN LYS THR GLU LEU GLN ALA ILE TYR LEU SEQRES 38 A 534 ALA LEU GLN ASP SER GLY LEU GLU VAL ASN ILE VAL THR SEQRES 39 A 534 ASP SER GLN TYR ALA LEU GLY ILE ILE GLN ALA GLN PRO SEQRES 40 A 534 ASP GLN SER GLU SER GLU LEU VAL ASN GLN ILE ILE GLU SEQRES 41 A 534 GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU ALA TRP VAL SEQRES 42 A 534 PRO SEQRES 1 B 422 THR VAL PRO VAL LYS LEU LYS PRO GLY MET ASP GLY PRO SEQRES 2 B 422 LYS VAL LYS GLN TRP PRO LEU THR GLU GLU LYS ILE LYS SEQRES 3 B 422 ALA LEU VAL GLU ILE CYS THR GLU MET GLU LYS GLU GLY SEQRES 4 B 422 LYS ILE SER LYS ILE GLY PRO GLU ASN PRO TYR ASN THR SEQRES 5 B 422 PRO VAL PHE ALA ILE LYS LYS LYS ASP SER THR LYS TRP SEQRES 6 B 422 ARG LYS LEU VAL ASP PHE ARG GLU LEU ASN LYS ARG THR SEQRES 7 B 422 GLN ASP PHE TRP GLU VAL GLN LEU GLY ILE PRO HIS PRO SEQRES 8 B 422 ALA GLY LEU LYS LYS LYS LYS SER VAL THR VAL LEU ASP SEQRES 9 B 422 VAL GLY ASP ALA TYR PHE SER VAL PRO LEU ASP GLU ASP SEQRES 10 B 422 PHE ARG LYS TYR THR ALA PHE THR ILE PRO SER ILE ASN SEQRES 11 B 422 ASN LYS THR PRO GLY ILE ARG TYR GLN TYR ASN VAL LEU SEQRES 12 B 422 PRO GLN GLY TRP LYS GLY SER PRO ALA ILE PHE GLN SER SEQRES 13 B 422 SER MET THR LYS ILE LEU GLU PRO PHE ARG LYS GLN ASN SEQRES 14 B 422 PRO ASP ILE VAL ILE TYR GLN TYR MET ASP ASP LEU TYR SEQRES 15 B 422 VAL GLY SER ASP LEU GLU ILE GLY GLN HIS ARG THR LYS SEQRES 16 B 422 ILE GLU GLU LEU ARG GLN HIS LEU LEU ARG TRP GLY LEU SEQRES 17 B 422 THR THR PRO ASP LYS LYS HIS GLN LYS GLU PRO PRO PHE SEQRES 18 B 422 LEU TRP MET GLY TYR GLU LEU HIS PRO ASP LYS TRP THR SEQRES 19 B 422 VAL GLN PRO ILE VAL LEU PRO GLU LYS ASP SER TRP THR SEQRES 20 B 422 VAL ASN ASP ILE GLN LYS LEU VAL GLY LYS LEU ASN TRP SEQRES 21 B 422 ALA SER GLN ILE TYR PRO GLY ILE LYS VAL ARG GLN LEU SEQRES 22 B 422 CYS LYS LEU LEU ARG GLY THR LYS ALA LEU THR GLU VAL SEQRES 23 B 422 ILE PRO LEU THR GLU GLU ALA GLU LEU GLU LEU ALA GLU SEQRES 24 B 422 ASN ARG GLU ILE LEU LYS GLU PRO VAL HIS GLY VAL TYR SEQRES 25 B 422 TYR ASP PRO SER LYS ASP LEU ILE ALA GLU ILE GLN LYS SEQRES 26 B 422 GLN GLY GLN GLY GLN TRP THR TYR GLN ILE TYR GLN GLU SEQRES 27 B 422 PRO PHE LYS ASN LEU LYS THR GLY LYS TYR ALA ARG MET SEQRES 28 B 422 ARG GLY ALA HIS THR ASN ASP VAL LYS GLN LEU THR GLU SEQRES 29 B 422 ALA VAL GLN LYS ILE THR THR GLU SER ILE VAL ILE TRP SEQRES 30 B 422 GLY LYS THR PRO LYS PHE LYS LEU PRO ILE GLN LYS GLU SEQRES 31 B 422 THR TRP GLU THR TRP TRP THR GLU TYR TRP GLN ALA THR SEQRES 32 B 422 TRP ILE PRO GLU TRP GLU PHE VAL ASN THR PRO PRO LEU SEQRES 33 B 422 VAL LYS LEU TRP TYR GLN MODRES 2HNY CSD A 280 CYS 3-SULFINOALANINE HET CSD A 280 8 HET PO4 A1300 5 HET PO4 A1301 5 HET PO4 A1302 5 HET MG A1303 1 HET NVP A 999 20 HETNAM CSD 3-SULFINOALANINE HETNAM PO4 PHOSPHATE ION HETNAM MG MAGNESIUM ION HETNAM NVP 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2- HETNAM 2 NVP B:2',3'-E][1,4]DIAZEPIN-6-ONE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE HETSYN NVP NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE FORMUL 1 CSD C3 H7 N O4 S FORMUL 3 PO4 3(O4 P 3-) FORMUL 6 MG MG 2+ FORMUL 7 NVP C15 H14 N4 O FORMUL 8 HOH *79(H2 O) HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ALA A 114 VAL A 118 5 5 HELIX 5 5 ASP A 121 LYS A 126 1 6 HELIX 6 6 GLY A 155 ASN A 175 1 21 HELIX 7 7 GLU A 194 TRP A 212 1 19 HELIX 8 8 ASP A 218 GLN A 222 5 5 HELIX 9 9 VAL A 254 SER A 268 1 15 HELIX 10 10 VAL A 276 LEU A 282 1 7 HELIX 11 11 THR A 296 LEU A 310 1 15 HELIX 12 12 ASN A 363 GLY A 384 1 22 HELIX 13 13 GLN A 394 TYR A 405 1 12 HELIX 14 14 THR A 473 SER A 489 1 17 HELIX 15 15 SER A 499 ALA A 508 1 10 HELIX 16 16 SER A 515 LYS A 528 1 14 HELIX 17 17 THR B 27 GLU B 44 1 18 HELIX 18 18 PHE B 77 THR B 84 1 8 HELIX 19 19 GLY B 112 VAL B 118 5 7 HELIX 20 20 PHE B 124 ALA B 129 5 6 HELIX 21 21 SER B 134 LYS B 138 5 5 HELIX 22 22 LYS B 154 LYS B 166 1 13 HELIX 23 23 LEU B 168 ASN B 175 1 8 HELIX 24 24 GLU B 194 ARG B 211 1 18 HELIX 25 25 LEU B 228 TYR B 232 5 5 HELIX 26 26 THR B 253 GLN B 269 1 17 HELIX 27 27 GLN B 278 LEU B 283 1 6 HELIX 28 28 THR B 296 LYS B 311 1 16 HELIX 29 29 ASN B 363 GLY B 384 1 22 HELIX 30 30 GLN B 394 TRP B 402 1 9 HELIX 31 31 THR B 403 TYR B 405 5 3 HELIX 32 32 PRO B 420 TRP B 426 1 7 SHEET 1 A 3 ILE A 47 LYS A 49 0 SHEET 2 A 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 A 3 PHE A 130 ILE A 132 -1 N ILE A 132 O ILE A 142 SHEET 1 B 2 VAL A 60 ILE A 63 0 SHEET 2 B 2 ARG A 72 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 C 3 SER A 105 ASP A 110 0 SHEET 2 C 3 ASP A 186 SER A 191 -1 O VAL A 189 N THR A 107 SHEET 3 C 3 VAL A 179 TYR A 183 -1 N VAL A 179 O GLY A 190 SHEET 1 D 4 PHE A 227 TRP A 229 0 SHEET 2 D 4 TYR A 232 LEU A 234 -1 O LEU A 234 N PHE A 227 SHEET 3 D 4 LYS A 238 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 4 D 4 GLY A 316 VAL A 317 -1 O GLY A 316 N TRP A 239 SHEET 1 E 2 TRP A 252 THR A 253 0 SHEET 2 E 2 VAL A 292 ILE A 293 -1 O ILE A 293 N TRP A 252 SHEET 1 F 5 LYS A 347 TYR A 354 0 SHEET 2 F 5 TRP A 337 GLU A 344 -1 N ILE A 341 O LYS A 350 SHEET 3 F 5 ILE A 326 LYS A 331 -1 N ILE A 326 O TYR A 342 SHEET 4 F 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 F 5 TRP A 414 PHE A 416 1 O GLU A 415 N PHE A 389 SHEET 1 G 2 HIS A 361 THR A 362 0 SHEET 2 G 2 GLN A 512 SER A 513 -1 O GLN A 512 N THR A 362 SHEET 1 H 5 GLN A 464 VAL A 466 0 SHEET 2 H 5 GLY A 456 THR A 459 -1 N TYR A 457 O LYS A 465 SHEET 3 H 5 THR A 439 VAL A 442 -1 N TYR A 441 O VAL A 458 SHEET 4 H 5 GLU A 492 THR A 497 1 O VAL A 496 N PHE A 440 SHEET 5 H 5 LYS A 530 TRP A 535 1 O TYR A 532 N ILE A 495 SHEET 1 I 3 ILE B 47 LYS B 49 0 SHEET 2 I 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 I 3 PHE B 130 ILE B 132 -1 N ILE B 132 O ILE B 142 SHEET 1 J 2 VAL B 60 LYS B 64 0 SHEET 2 J 2 TRP B 71 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 K 3 SER B 105 ASP B 110 0 SHEET 2 K 3 ASP B 186 SER B 191 -1 O VAL B 189 N THR B 107 SHEET 3 K 3 VAL B 179 TYR B 183 -1 N TYR B 181 O TYR B 188 SHEET 1 L 5 LYS B 347 ALA B 355 0 SHEET 2 L 5 GLN B 336 GLU B 344 -1 N ILE B 341 O LEU B 349 SHEET 3 L 5 ILE B 326 GLY B 333 -1 N GLN B 332 O GLN B 336 SHEET 4 L 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 L 5 GLU B 413 PHE B 416 1 O GLU B 415 N LEU B 391 LINK C LEU A 279 N CSD A 280 1555 1555 1.33 LINK C CSD A 280 N LYS A 281 1555 1555 1.33 LINK OD2 ASP A 443 MG MG A1303 1555 1555 2.50 LINK O HOH A1037 MG MG A1303 1555 1555 2.39 CISPEP 1 PRO A 225 PRO A 226 0 0.04 CISPEP 2 PRO A 420 PRO A 421 0 -0.08 SITE 1 AC1 1 ARG A 461 SITE 1 AC2 6 GLY A 436 ALA A 437 ASN A 460 ARG A 461 SITE 2 AC2 6 LYS B 82 ALA B 288 SITE 1 AC3 5 MET A 41 LYS A 73 PHE A 116 TYR A 146 SITE 2 AC3 5 GLN A 151 SITE 1 AC4 3 VAL A 442 ASP A 443 HOH A1037 SITE 1 AC5 11 LEU A 100 LYS A 101 VAL A 106 VAL A 179 SITE 2 AC5 11 TYR A 181 TYR A 188 GLY A 190 PHE A 227 SITE 3 AC5 11 HIS A 235 PRO A 236 TYR A 318 CRYST1 139.600 115.000 65.600 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007163 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008696 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015244 0.00000 MASTER 340 0 6 32 39 0 9 6 0 0 0 75 END